A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Reviva Pharmaceuticals Holdings, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 106,100 shares of RVPH stock, worth $100,795. This represents 0.0% of its overall portfolio holdings.

Number of Shares
106,100
Previous 121,800 12.89%
Holding current value
$100,795
Previous $460,000 70.65%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$3.56 - $6.04 $126,810 - $215,150
35,621 Added 369.74%
45,255 $233,000
Q3 2023

Nov 14, 2023

SELL
$3.91 - $5.9 $287,725 - $434,163
-73,587 Reduced 88.42%
9,634 $47,000
Q2 2023

Aug 14, 2023

BUY
$4.42 - $8.55 $352,251 - $681,392
79,695 Added 2260.21%
83,221 $487,000
Q1 2023

May 15, 2023

BUY
$3.79 - $4.87 $13,363 - $17,171
3,526 New
3,526 $14,000
Q3 2022

Nov 14, 2022

BUY
$0.14 - $2.66 $5,632 - $107,017
40,232 New
40,232 $64,000

Others Institutions Holding RVPH

About REVIVA PHARMACEUTICALS HOLDINGS, INC.


  • Ticker RVPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,442,900
  • Market Cap $19.4M
  • Description
  • Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP506...
More about RVPH
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.